在儿科结核病中异化的有效性:一个个体参与者数据的元分析
Agathe Béranger1,2,3,4,5, Belén P Solans1,2,5, Ryo Miyakawa1,2
1Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, United States of America.
The European respiratory journal
|December 18, 2025
概括
对儿童结核病的异化物剂量通常是有效的,但结果与营养状况有关. 根据遗传学和营养来调整剂量,可以改善所有儿童的治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
背景情况:
- 异化物是结核病的关键治疗方法.
- 在儿童中优化异化剂量对于有效的结核病管理至关重要.
研究的目的:
- 检查异化物暴露与结核病儿童的临床结果之间的联系.
- 在儿科患者中开发异化的药理动力学模型.
- 为了优化儿童的异化剂量方案.
主要方法:
- 观察性研究的个人参与者数据元分析,涉及治疗药物敏感结核病的儿童 (0-18岁).
- 混合效应逻辑回归分析了异化物暴露与临床结果之间的关系.
- 非线性混合效应建模描述了药物动力学参数,针对23.4mg·h·L-1.1的度-时间曲线 (AUCss) 下的成年人区域.
主要成果:
- 不利的结局与年龄Z-分数 (OR 0.96) 的较低BMI有关.
- 异化物暴露受NAT2基因型,体重,年龄和营养状况的影响.
- 药理动力学目标的实现因NAT2基因型 (71.7%用于缓慢代谢者 vs. 29.5%用于快速代谢者) 和营养状况 (50.5%用于BAZ>0 vs. 42.6%用于营养不良患者) 而有显著差异.
- 基于模型的剂量建议在快速代谢者,特别是营养不良儿童中使用更高的异化剂.
结论:
- 较低的BMI对于年龄Z-score是不利临床结果的唯一预测因素.
- 目前由世卫组织推的异化剂量方案得到支持.
- 根据NAT2基因型和营养状况调整异化物剂量可以帮助在所有儿童中实现治疗目标.
相关概念视频
Pulmonary Tuberculosis V
516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Pulmonary Tuberculosis IV
461
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461
Pulmonary Tuberculosis I
800
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
800
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Pulmonary Tuberculosis III
879
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
879


